Life Sciences Clinical Intelligence Platform
phData · Intelligence & Research
Certification per AWS Marketplace.
Evidence tier Source Confirmed · 4 captures on record
What the publisher says
As described on AWS Marketplace.
Clinical trials are slowed by predictable, expensive manual work: protocol teams cross-reference PDFs by hand, statisticians discover CDISC formatting issues during final quality control, and study teams set inclusion and exclusion criteria without confirming that the intended population exists at scale. phData’s Clinical Intelligence Platform applies AI to these workflow bottlenecks, helping clinical operations, biometrics, data management, and R&D technology teams make faster, better-informed decisions.
The platform brings together eight clinical-trial accelerators: eCRF Generator, CDISC Validator, Eligibility Risk Shield, Therapeutic Area Radar, Trial Comparator, Outcome Measure Intel, Trial Power, and Competitive Landscape. Together, they support protocol-to-EDC conversion, study and endpoint comparison, CDISC conformance checks during statistical work, regulatory signal monitoring across therapeutic areas, enrollment-risk analysis, statistical power planning, and competitive trial intelligence. Outputs are designed to retain context and traceability, including protocol markup and structured findings that teams can review as part of their existing workflows.
Show the rest of the publisher’s description (1 more line)
The solution is designed to connect with existing documents, statistical outputs, and data sources in the customer’s AWS environment rather than requiring replacement of core clinical systems. phData delivers the accelerators through Forge™ sprints, an AI-native delivery methodology that ends each sprint with a working, validated tool. Organizations can begin with a focused clinical use case, assess readiness through a short digital assessment, and expand as priorities and platform maturity evolve.
Highlights
Highlighted by the publisher on AWS Marketplace.
Accelerate clinical trial workflows by reducing manual effort across protocol-to-EDC conversion, statistical validation, study comparison, and enrollment-risk assessment.
Improve quality, regulatory readiness, and enrollment confidence by identifying data issues earlier, grounding eligibility criteria in real-world population signals, and preserving review context.
Adopt AI in your existing AWS environment through focused, repeatable phData Forge™ sprints, without replacing core clinical systems or requiring a wholesale data migration.
Agent build and provenance
See the full provenance
The layer-by-layer build, the evidence behind each claim, the risk basis and the cross-marketplace links are open to any account. Some rows are disclosed, some the source leaves Unknown; a free account shows you which.
Compliance
- FedRAMPConfirmedNot listed90%, registry-checkedNo FedRAMP Marketplace entry matched this vendor's domain, checked 2026-08-27registry recordas observed 2026-08-27
Confirmed means matched to a public authoritative registry. Claimed means the vendor or its listing states it, not yet cross-checked. A framework not shown was not found in any source we hold, which is not evidence against it. Not listed means a scoped registry check found no match for this vendor's domain: a No is a scoped registry check, not a compliance judgment. Confidence bands: 95% domain-verified, 90% registry-checked, 80% self-attested, 70% weak signal. Self-attested items marked “vendor's site” are gathered from the vendor's own website and are not verified by us.
Vendor
External enrichment · as of 2026-08-29
Sources
Publisher resources
1 linkLinked repositories
Unknown means this listing does not publish a repository. It is not a statement that the code is closed, and a linked repository is not a claim that the publisher wrote it: the registry computes that relationship privately and does not publish it.
Evidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.